Menu Close

Articles on SARS-CoV-2

Displaying 61 - 80 of 583 articles

Millions of U.S. children between the ages of 6 months and 4 years will soon be eligible for COVID-19 shots. FatCamera/E+ via Getty Images

At last, COVID-19 shots for little kids – 5 essential reads

The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots for this group will be available within days.
Testing wastewater for the presence of diseases has grown in popularity during the COVID-19 pandemic. (Shutterstock)

Targeted wastewater surveillance has a history of social and ethical concerns

The COVID-19 pandemic has seen an increase in wastewater testing to monitor the spread of the virus. But historical cases show that targeted surveillance can further marginalize vulnerable populations.
Global Justice campaigners in London stand by fake coffins to highlight global COVID-19 deaths. If pharma companies waived intellectual property rights, it would be easier for low- and middle-income countries to access COVID-19 vaccines. (AP Photo/Alastair Grant)

We still need a vaccine patent waiver, but not the one on offer at the World Trade Organization meeting

Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
Researchers can test blood samples taken for other reasons to see if patients have previously had COVID-19. Don Bartletti/Los Angeles Times via Getty Images

COVID-19 official counts can miss mild cases – here’s how serosurveys that analyze blood for signs of past infection can help

Your blood can hold a record of past illnesses. That information can reveal how many people have had a certain infection – like 58% of Americans having had COVID-19 by the end of February 2022.
Dozens of coronavirus vaccines are in clinical trials in the U.S. Joao Paulo Burini/Moment via Getty Images

Will new vaccines be better at fighting coronavirus variants? 5 questions answered

Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development will likely offer better protection.

Top contributors

More